Common (5-15% of users): Mild injection site reactions, minor digestive changes Uncommon (1-5%): Sleep changes, temporary fatigue, mild headache Rare (under 1%): Dizziness, flushing, mood changes Very Rare: Serious adverse effects rarely reported in community use Theoretical Concerns BPC-157s ability to stimulate angiogenesis (blood vessel formation) raises theoretical questions about its use in individuals with active cancer or high cancer risk
That mechanism is plausible and specific, but it was demonstrated on isolated follicles and cells, not on a scalp
Research shows its more effective than oral glutathione alone, boosting glutathione levels and improving markers of healthy aging
Ingestion of creatine seems to increase Ca 2+ -ATPase, resulting in less available free Ca 2+ buffering (Kim et al., 2015)
Can BPC-157 be used as a medical treatment